4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-26-034066
President & CIO sold 335,174 shares at an average $36.88 ($12,360,813)
- President & CIO acquired 335,174 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sukhatme Mayukh · President & CIO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-19 | Exercise or conversion : show line 1 in the form | +172,899 | $3.85 | $665,661 | 18,803,638 | D |
| 2026-08-19 | Sale : show line 2 in the form | −172,899 | $37.17 | $6,426,656 | 18,630,739 | D |
| 2026-08-20 | Exercise or conversion : show line 3 in the form | +17,519 | $3.85 | $67,448 | 18,648,258 | D |
| 2026-08-20 | Sale : show line 4 in the form | −17,519 | $37.30 | $653,459 | 18,630,739 | D |
| 2026-08-21 | Exercise or conversion : show line 5 in the form | +144,756 | $3.85 | $557,311 | 18,775,495 | D |
| 2026-08-21 | Sale : show line 6 in the form | −144,756 | $36.48 | $5,280,699 | 18,630,739 | D |
| Open-market sales · 335,174 sh · avg $36.88 · $12,360,813 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-19 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −172,899 | 13,386,638 | D |
| 2026-08-20 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −17,519 | 13,369,119 | D |
| 2026-08-21 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −144,756 | 13,224,363 | D |
Loading xslF345X06/form4.xml…